Pangenomic Health Inc.
PGHIF
$1.46
$0.3632.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 181.67% | 105.92% | 29.44% | -15.94% | -68.49% |
| Gross Profit | -181.67% | -105.92% | -29.44% | 15.94% | 68.49% |
| SG&A Expenses | 158.36% | -20.89% | -55.05% | -70.44% | -60.61% |
| Depreciation & Amortization | -95.24% | -80.43% | -56.52% | -31.87% | -6.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 157.40% | 12.65% | -34.36% | -60.01% | -65.48% |
| Operating Income | -157.40% | -12.65% | 34.36% | 60.01% | 65.48% |
| Income Before Tax | 4.73% | 51.75% | -82.30% | -25.68% | 70.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.73% | 51.75% | -82.30% | -25.68% | 70.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.73% | 51.75% | -82.30% | -25.68% | 70.43% |
| EBIT | -157.40% | -12.65% | 34.36% | 60.01% | 65.48% |
| EBITDA | -160.06% | -13.57% | 34.22% | 60.14% | 65.71% |
| EPS Basic | 59.74% | 74.39% | 35.70% | 50.77% | 88.21% |
| Normalized Basic EPS | 34.63% | 65.41% | 78.08% | 80.91% | 75.89% |
| EPS Diluted | 59.74% | 74.39% | 35.70% | 50.77% | 88.21% |
| Normalized Diluted EPS | 34.63% | 65.41% | 78.08% | 80.91% | 75.89% |
| Average Basic Shares Outstanding | 160.91% | 180.82% | 202.96% | 143.55% | 115.27% |
| Average Diluted Shares Outstanding | 160.91% | 180.82% | 202.96% | 143.55% | 115.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |